Press releases

15 November 2005

Apax Partners’ Funds announce the successful completion of the acquisition of Panrico

Funds advised by Apax Partners, today announced the successful closing of the acquisition of 100% of the share capital of Panrico, S.A. from the Costafreda Family, Caixa Holding, BancSabadell and other minority shareholders.

7 November 2005

Apax Partners, L.P. to acquire majority ownership interest in Spectrum Laboratory Network

Spectrum Laboratory Network, a leading regional provider of clinical laboratory and disease screening services, and Apax Partners, L.P., one of the world's leading private equity investment groups, today announced that funds advised by Apax Partners will acquire a majority ownership interest in Spectrum.

11 October 2005

Apax Partners Funds, Saban Capital Group and Arkin Communications (Apax Saban Arkin Group) completes acquisition of controlling interest in leading Israeli telecom company Bezeq

The group has acquired 30% of Bezeq's shares for 4.246 billion NIS ($923 million) and an option to purchase an additional 10.7% of the shares within the next four years.

4 August 2005

Apax Partners’ Funds to acquire Grupo Panrico

Funds advised by Apax Partners today announced an agreement to acquire a majority shareholding in Panrico, S.A. from the Costafreda Family, La Caixa and other minority shareholders.

3 August 2005

Funds advised by Apax Partners announce the successful completion of the acquisition of a majority shareholding in Travelex

Funds advised by Apax Partners today announced the successful closing of the acquisition of a controlling majority stake in Travelex, the world's largest foreign exchange specialist, following regulatory approval.

18 July 2005

Xanodyne Pharmaceuticals, backed by MPM Capital-led syndicate, approved to acquire pain management portfolio

Xanodyne Pharmaceuticals, Inc., a specialty pharmaceutical company, today announced that the Bankruptcy Court for the District of Delaware has approved its bid to acquire the pharmaceutical assets of aaiPharma.